The study identifies the core polypeptide VP3 as the rotavirus guanylyltransferase responsible for mRNA capping.
Answers are grounded in this paper and cite their sources.
VP3 identification as rotavirus guanylyltransferase may guide antiviral targeting; leaves open in vivo efficacy and clinical translation.
Rotaviruses transcribe mRNA containing a 7mGpppGmp cap at the 5' end in vitro. Guanylyltransferase activity associated with the viral particle was detected by SDS-PAGE due to the formation of a nucleotide-enzyme complex when the virus was incubated with [alpha-32P]GTP. Using purified viral particles it was shown that only the core polypeptide VP3 exhibits the ability to form a complex with the nucleotide. The reaction is specific for GTP or dGTP when Mg2+ is used as a cofactor. The reaction also depends on the incubation temperature and the pH, as described for other guanylyltransferases. The GMP-VP3 complex transfers the GMP to pyrophosphate, synthesizing GTP or GDP, resulting in the formation of a GpppG cap. These properties of the complex allowed the core polypeptide VP3 to be identified as the rotavirus guanylyltransferase.
No takes yet. Share an insight, caveat, or question.
Pizarro et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: